Dear Quebec party leaders,
What if we told you about a sector in Quebec that:
- Supports over 55,000 highly skilled, well-paid jobs
- Generates $7.5 billion in economic activity
- Invests over $700 million in R&D every year
- Delivers a return of approximately $3 to our economy for every $1 invested
You’d probably want to make it a priority. Attract it. Grow it. Celebrate it.
This sector already exists: it’s innovative medicines—a true engine of prosperity that protects Quebecers’ health.
The next government has a real opportunity to make faster access to innovative medicines a lever for efficiency and growth.
There’s no need to create costly new programs. The solution lies in targeted action: accelerating access to treatments for patients.
When a treatment passes through Health Canada’s rigorous scientific evaluation stages and those of the relevant bodies, its value is established. Allowing access without delay generates immediate impact:
- Faster care that improves patients’ quality of life and supports their return to an active life
- A strong signal that attracts private investment, retains top talent, and improves productivity
- A proactive policy that positions Quebec as a global leader in health
This is a strategic opportunity, a concrete decision, achievable quickly, with immediate economic and human benefits.
The innovations exist. Patients are waiting for them. Quebec has everything it needs to act.
We want to work with you. Together, let’s make access to innovation a lever for health and prosperity for all.
Dr. Bettina Hamelin
President and CEO
Innovative Medicines Canada
